vs
Side-by-side financial comparison of HEARTLAND EXPRESS INC (HTLD) and Varex Imaging Corp (VREX). Click either name above to swap in a different company.
Varex Imaging Corp is the larger business by last-quarter revenue ($209.6M vs $179.4M, roughly 1.2× HEARTLAND EXPRESS INC). Varex Imaging Corp runs the higher net margin — 1.1% vs -10.8%, a 11.9% gap on every dollar of revenue. On growth, Varex Imaging Corp posted the faster year-over-year revenue change (4.9% vs -26.1%). Varex Imaging Corp produced more free cash flow last quarter ($-26.8M vs $-44.2M). Over the past eight quarters, Varex Imaging Corp's revenue compounded faster (0.8% CAGR vs -18.5%).
Heartland Express is an American trucking company headquartered in North Liberty, Iowa. The company offers truckload shipping services across the United States.
Varex Imaging Corp is a global supplier of advanced imaging components and solutions, including X-ray tubes, digital flat panel detectors, and image processing software. Its products serve medical imaging, radiation oncology, and industrial non-destructive testing segments, with customers across key global markets.
HTLD vs VREX — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $179.4M | $209.6M |
| Net Profit | $-19.4M | $2.3M |
| Gross Margin | — | 33.3% |
| Operating Margin | -12.7% | 7.3% |
| Net Margin | -10.8% | 1.1% |
| Revenue YoY | -26.1% | 4.9% |
| Net Profit YoY | -949.2% | 866.7% |
| EPS (diluted) | $-0.24 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $209.6M | ||
| Q4 25 | $179.4M | $228.9M | ||
| Q3 25 | $196.5M | $203.0M | ||
| Q2 25 | $210.4M | $212.9M | ||
| Q1 25 | $219.4M | $199.8M | ||
| Q4 24 | $242.6M | — | ||
| Q3 24 | $259.9M | $205.7M | ||
| Q2 24 | $274.8M | $209.1M |
| Q1 26 | — | $2.3M | ||
| Q4 25 | $-19.4M | $12.2M | ||
| Q3 25 | $-8.3M | $-89.1M | ||
| Q2 25 | $-10.9M | $6.9M | ||
| Q1 25 | $-13.9M | $-300.0K | ||
| Q4 24 | $-1.9M | — | ||
| Q3 24 | $-9.3M | $-51.1M | ||
| Q2 24 | $-3.5M | $1.4M |
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
| Q1 26 | — | 7.3% | ||
| Q4 25 | -12.7% | 8.6% | ||
| Q3 25 | -3.7% | -39.8% | ||
| Q2 25 | -5.9% | 10.4% | ||
| Q1 25 | -6.8% | 5.6% | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | -2.7% | 5.3% | ||
| Q2 24 | 0.1% | 4.4% |
| Q1 26 | — | 1.1% | ||
| Q4 25 | -10.8% | 5.3% | ||
| Q3 25 | -4.2% | -43.9% | ||
| Q2 25 | -5.2% | 3.2% | ||
| Q1 25 | -6.3% | -0.2% | ||
| Q4 24 | -0.8% | — | ||
| Q3 24 | -3.6% | -24.8% | ||
| Q2 24 | -1.3% | 0.7% |
| Q1 26 | — | $0.05 | ||
| Q4 25 | $-0.24 | $0.29 | ||
| Q3 25 | $-0.11 | $-2.15 | ||
| Q2 25 | $-0.14 | $0.17 | ||
| Q1 25 | $-0.18 | $-0.01 | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-0.12 | $-1.25 | ||
| Q2 24 | $-0.04 | $0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.5M | $125.6M |
| Total DebtLower is stronger | $154.1M | $367.6M |
| Stockholders' EquityBook value | $755.3M | $476.9M |
| Total Assets | $1.2B | $1.1B |
| Debt / EquityLower = less leverage | 0.20× | 0.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $125.6M | ||
| Q4 25 | $18.5M | $155.1M | ||
| Q3 25 | $32.7M | $152.6M | ||
| Q2 25 | $22.9M | $223.0M | ||
| Q1 25 | $23.9M | $212.6M | ||
| Q4 24 | $12.8M | — | ||
| Q3 24 | $30.7M | $200.5M | ||
| Q2 24 | $23.9M | $190.0M |
| Q1 26 | — | $367.6M | ||
| Q4 25 | $154.1M | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | $187.9M | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
| Q1 26 | — | $476.9M | ||
| Q4 25 | $755.3M | $472.6M | ||
| Q3 25 | $775.6M | $455.3M | ||
| Q2 25 | $786.7M | $549.7M | ||
| Q1 25 | $807.7M | $540.2M | ||
| Q4 24 | $822.6M | — | ||
| Q3 24 | $825.7M | $529.1M | ||
| Q2 24 | $836.8M | $581.2M |
| Q1 26 | — | $1.1B | ||
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | $1.3B | $1.1B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.3B | $1.3B | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.4B | $1.3B |
| Q1 26 | — | 0.77× | ||
| Q4 25 | 0.20× | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | 0.23× | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.9M | $-16.1M |
| Free Cash FlowOCF − Capex | $-44.2M | $-26.8M |
| FCF MarginFCF / Revenue | -24.6% | -12.8% |
| Capex IntensityCapex / Revenue | 33.0% | 5.1% |
| Cash ConversionOCF / Net Profit | — | -7.00× |
| TTM Free Cash FlowTrailing 4 quarters | $-66.9M | $-13.3M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $14.9M | $7.9M | ||
| Q3 25 | $27.5M | $7.7M | ||
| Q2 25 | $21.0M | $16.6M | ||
| Q1 25 | $25.8M | $9.5M | ||
| Q4 24 | $37.8M | — | ||
| Q3 24 | $35.6M | $25.9M | ||
| Q2 24 | $40.0M | $8.0M |
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $-44.2M | $2.3M | ||
| Q3 25 | $-12.2M | $1.4M | ||
| Q2 25 | $-12.8M | $9.8M | ||
| Q1 25 | $2.3M | $5.3M | ||
| Q4 24 | $-45.5M | — | ||
| Q3 24 | $24.6M | $19.9M | ||
| Q2 24 | $29.4M | $3.3M |
| Q1 26 | — | -12.8% | ||
| Q4 25 | -24.6% | 1.0% | ||
| Q3 25 | -6.2% | 0.7% | ||
| Q2 25 | -6.1% | 4.6% | ||
| Q1 25 | 1.0% | 2.7% | ||
| Q4 24 | -18.8% | — | ||
| Q3 24 | 9.5% | 9.7% | ||
| Q2 24 | 10.7% | 1.6% |
| Q1 26 | — | 5.1% | ||
| Q4 25 | 33.0% | 2.4% | ||
| Q3 25 | 20.2% | 3.1% | ||
| Q2 25 | 16.1% | 3.2% | ||
| Q1 25 | 10.7% | 2.1% | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 4.2% | 2.9% | ||
| Q2 24 | 3.8% | 2.2% |
| Q1 26 | — | -7.00× | ||
| Q4 25 | — | 0.65× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 5.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HTLD
Segment breakdown not available.
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
